Niemann-Pick disease (NPD) type A and type B are part of the spectrum disease of the acid sphingomyelinase deficiency (ASMD). Plasma lipid abnormalities are frequently associated with both NPD-A and NPD-B, and include decreased high-density lipoprotein cholesterol (HDL-C), increased lowdensity lipoprotein cholesterol (LDL-C), and hypertriglyceridemia. The atherogenic lipid profile has been associated to early atherosclerotic vascular disease and coronary artery disease in NPD-B patients. Thus, early treatment of dyslipidemia in these patients is advisable. We present here a pediatric case of NPD-B with an atherogenic lipid profile not responding to lifestyle changes, low fat diet, and daily supplementation with plant sterols. We reviewed the existing literature about the treatment strategies for dyslipidemia in ASMD patients, with a special focus on the pediatric age. Finally, we speculated on the mechanisms underlying dyslipidemia in this disorder. The clinical experiences in lipid-lowering strategies in NPD-B patients are limited, in particular in the pediatric age. Olipudase alfa appears as the most promising candidate for improving lipid profile. Since olipudase alfa is not yet approved and, due to its costs, it will probably not be available for all patients worldwide, further research is needed to broaden our knowledge on this clinical need and to evaluate the efficacy and the long-term effects of lipid-lowering agents in ASMD patients. A deep understanding of the pathophysiology of dyslipidemia in ASMD may promote the identification of new targets and support the identification of new therapeutic strategies. (c) 2022 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Atherogenic lipid profile in patients with Niemann-Pick disease type B: What treatment strategies? / Maines, Evelina; Franceschi, Roberto; Rizzardi, Caterina; Deodato, Federica; Piccoli, Giovanni; Gragnaniello, Vincenza; Burlina, Alberto; Soffiati, Massimo. - In: JOURNAL OF CLINICAL LIPIDOLOGY. - ISSN 1933-2874. - 16:2(2022), pp. 143-154. [10.1016/j.jacl.2022.01.008]

Atherogenic lipid profile in patients with Niemann-Pick disease type B: What treatment strategies?

Piccoli, Giovanni;
2022-01-01

Abstract

Niemann-Pick disease (NPD) type A and type B are part of the spectrum disease of the acid sphingomyelinase deficiency (ASMD). Plasma lipid abnormalities are frequently associated with both NPD-A and NPD-B, and include decreased high-density lipoprotein cholesterol (HDL-C), increased lowdensity lipoprotein cholesterol (LDL-C), and hypertriglyceridemia. The atherogenic lipid profile has been associated to early atherosclerotic vascular disease and coronary artery disease in NPD-B patients. Thus, early treatment of dyslipidemia in these patients is advisable. We present here a pediatric case of NPD-B with an atherogenic lipid profile not responding to lifestyle changes, low fat diet, and daily supplementation with plant sterols. We reviewed the existing literature about the treatment strategies for dyslipidemia in ASMD patients, with a special focus on the pediatric age. Finally, we speculated on the mechanisms underlying dyslipidemia in this disorder. The clinical experiences in lipid-lowering strategies in NPD-B patients are limited, in particular in the pediatric age. Olipudase alfa appears as the most promising candidate for improving lipid profile. Since olipudase alfa is not yet approved and, due to its costs, it will probably not be available for all patients worldwide, further research is needed to broaden our knowledge on this clinical need and to evaluate the efficacy and the long-term effects of lipid-lowering agents in ASMD patients. A deep understanding of the pathophysiology of dyslipidemia in ASMD may promote the identification of new targets and support the identification of new therapeutic strategies. (c) 2022 National Lipid Association. Published by Elsevier Inc. All rights reserved.
2022
2
Maines, Evelina; Franceschi, Roberto; Rizzardi, Caterina; Deodato, Federica; Piccoli, Giovanni; Gragnaniello, Vincenza; Burlina, Alberto; Soffiati, Massimo
Atherogenic lipid profile in patients with Niemann-Pick disease type B: What treatment strategies? / Maines, Evelina; Franceschi, Roberto; Rizzardi, Caterina; Deodato, Federica; Piccoli, Giovanni; Gragnaniello, Vincenza; Burlina, Alberto; Soffiati, Massimo. - In: JOURNAL OF CLINICAL LIPIDOLOGY. - ISSN 1933-2874. - 16:2(2022), pp. 143-154. [10.1016/j.jacl.2022.01.008]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/379068
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact